Belgin Sever

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Cell Cycle Arrest

Oxidative Stress

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Archiv der Pharmazie

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Belgin Sever, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication. International journal of molecular sciences 25 (7) (2024)
Belgin Sever, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication. International journal of molecular sciences 25 (7) (2024)
Belgin Sever, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication. International journal of molecular sciences 25 (7) (2024)
Belgin Sever, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication. International journal of molecular sciences 25 (7) (2024)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Nilüfer Bayrak, Belgin Sever, Halilibrahim Çiftçi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
Scaffold Hopping and Structural Modification of NSC 663284: Discovery of Potent (Non)Halogenated Aminobenzoquinones. Biomedicines 12 (1) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Nilüfer Bayrak, Belgin Sever, Halilibrahim Çiftçi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
Scaffold Hopping and Structural Modification of NSC 663284: Discovery of Potent (Non)Halogenated Aminobenzoquinones. Biomedicines 12 (1) (2023)
Omur Guven, Belgin Sever, Faika Başoğlu-Ünal, Abdulilah Ece, Hiroshi Tateishi, Ryoko Koga, Mohamed Osman Radwan, Nefise Demir, Mustafa Can, Mutlu Dilsiz Aytemir, Jun-Ichiro Inoue, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi, Hasan DeMirci
Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Halilibrahim Çiftçi, Belgin Sever, Nusret Kaya, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects. Molecules (Basel, Switzerland) 28 (1) (2022)
Halilibrahim Çiftçi, Belgin Sever, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
In Vitro Cytotoxicity Evaluation of Plastoquinone Analogues against Colorectal and Breast Cancers along with In Silico Insights. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Belgin Sever, Halilibrahim Çiftçi, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita, Ayse Nazli Basak
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International journal of molecular sciences 23 (5) (2022)
Halilibrahim Çiftçi, Belgin Sever, Firdevs Ocak, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hasan DeMirci, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Amaç Fatih TuYuN
In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment. Molecules (Basel, Switzerland) 27 (3) (2022)
Mehlika Dilek Altintop, Belgin Sever, Gülşen Akalın Çiftçi, İpek Ertorun, İbrahim Ozkan Alatas, Ahmet Özdemir
A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition. Archiv der Pharmazie 355 (9) (2022)
Ahmet Özdemir, Halilibrahim Çiftçi, Belgin Sever, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Mehlika Dilek Altintop
A New Series of Indeno[1,2- c ]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy. Molecules (Basel, Switzerland) 27 (2) (2022)
Halilibrahim Çiftçi, Belgin Sever, Esra Ayan, Mustafa Can, Hasan DeMirci, Masami Otsuka, Amaç Fatih Tuyun, Hiroshi Tateishi, Mikako Fujita
Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Halilibrahim Çiftçi, Belgin Sever, Nusret Kaya, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects. Molecules (Basel, Switzerland) 28 (1) (2022)
Halilibrahim Çiftçi, Belgin Sever, Nusret Kaya, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Amaç Fatih Tuyun
Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects. Molecules (Basel, Switzerland) 28 (1) (2022)
Belgin Sever, Cüneyt Türkeş, Mehlika Dilek Altintop, Malihe Moradzadeh, Gulsen Akalin Ciftci, Sukru Beydemir
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie 354 (12) (2021)
Halilibrahim Çiftçi, Mohamed Osman Radwan, Belgin Sever, Ahmed K Hamdy, Safiye Emirdağ, Nafia Gökçe Ulusoy, Ece Sozer, Mustafa Can, Nurettin Yayli, Norie Araki, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Mehlika Dilek Altintop
EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy. International journal of molecular sciences 22 (20) (2021)
Belgin Sever, Hasan Soybir, Şennur Görgülü, Zerrin Cantürk, Mehlika Dilek Altintop
Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects. Molecules (Basel, Switzerland) 25 (21) (2020)
Belgin Sever, Gülşen Akalın Çiftçi, Mehlika Dilek Altintop
A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer. Archiv der Pharmazie 354 (1) (2020)
Belgin Sever, Mehlika Dilek Altintop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E Ellakwa, Hiroshi Tateishi, Mohamed Osman Radwan, Mahmoud A A Ibrahim, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi, Taha Farouk Shehata Ali
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules (Basel, Switzerland) 25 (21) (2020)
Gulsen Akalin Ciftci, Belgin Sever, Mehlika Dilek Altintop
Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells. Turkish journal of pharmaceutical sciences 16 (2) (2019)
Ahmet Özdemir, Belgin Sever, Mehlika Dilek Altintop, Elif Kaya Tilki, Miriş Dikmen
Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress. Molecules (Basel, Switzerland) 23 (9) (2018)
Mehlika Dilek Altintop, Belgin Sever, Gülşen Akalın Çiftçi, Ahmet Özdemir
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors. Molecules (Basel, Switzerland) 23 (6) (2018)
Ahmet Özdemir, Mehlika Dilek Altıntop, Belgin Sever, Hülya Karaca Gençer, Handan Açelya Kapkaç, Özlem Atlı, Merve Baysal
A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity. Molecules (Basel, Switzerland) 22 (12) (2017)